FDA permits marketing of devices to create arteriovenous fistula

July 4, 2018

(HealthDay)—The U.S. Food and Drug Administration has permitted marketing of two catheter-based devices designed to create an arteriovenous (AV) fistula in patients with chronic kidney disease in need of hemodialysis.

The devices are designed to create AV fistulas percutaneously; the AV fistulas are needed before can start hemodialysis. A catheter is inserted into a blood vessel in the arm and guided to the site of the planned fistula. The Ellipsys Vascular Access System and everlinQ endoAVF System use one and two catheters, respectively.

For the Ellipsys Vascular Access System, the FDA reviewed data from a study involving 103 patients. Three months after the procedure, 89.3 percent of the patients met the criteria for a usable AV fistula. To maintain the fistula, almost all patients (96.1 percent) required an additional procedure in the first 12 months. For the everlinQ endoAVF System, the FDA reviewed data from 60 patients in a multicenter study, as well as data from other studies. In the main study, 86.7 percent of patients met the criteria for a usable AV fistula within three months after the procedure. Overall, 96.7 percent of patients required an additional at the time that the fistula was created.

"With today's action, there will be additional, less-invasive vascular access options for patients who will require hemodialysis," Bram Zuckerman, M.D., director of the Division of Cardiovascular Devices in the FDA's Center for Devices and Radiological Health, said in a statement.

Explore further: New magnet technology creates easy blood access for hemodialysis patients

More information: More Information

Related Stories

New magnet technology creates easy blood access for hemodialysis patients

June 14, 2017
A new, minimally invasive system which uses radiofrequency energy instead of open surgery to create access for patients needing hemodialysis is reliable, with minimal complications, according to data published in the American ...

New research shows promise for improving vascular access for hemodialysis patients

August 16, 2017
Approximately 500,000 Americans with end-stage renal disease rely on hemodialysis to survive. Hemodialysis requires repeated access to the blood. Failure to maintain adequate access to the vasculature is a major cause of ...

Catheters linked with high risk of infections, heart problems, and death in dialysis patients

February 21, 2013
Dialysis patients using catheters to access the blood have the highest risks for death, infections, and cardiovascular events compared with patients using other types of vascular access, according to an analysis appearing ...

Racial disparities seen in initial access to blood flow for hemodialysis

April 29, 2015
Black and Hispanic patients will less frequently than white patients start hemodialysis with an arteriovenous fistula (connecting an artery to a vein for vascular access), a procedure for initial blood flow access known to ...

FDA permits marketing of new device for treating GI bleeding

May 9, 2018
(HealthDay)—The U.S. Food and Drug Administration has approved the new Hemospray device to help control bleeding of the gastrointestinal (GI) tract.

Recommended for you

Effective drug delivery to heart with tannic acid

September 18, 2018
Typical methods of drug delivery to the heart require surgical procedures involving incisions in the chest wall and bones. To efficiently treat cardiovascular and related vascular diseases without surgery, a KAIST research ...

Daily low-dose aspirin found to have no effect on healthy life span in older people

September 16, 2018
In a large clinical trial to determine the risks and benefits of daily low-dose aspirin in healthy older adults without previous cardiovascular events, aspirin did not prolong healthy, independent living (life free of dementia ...

Financial incentives for cholesterol control may be cost-effective

September 14, 2018
A program that offered financial incentives to both patients and their physicians to control low-density lipoproteins (LDL) cholesterol could be a cost-effective intervention for patients at high risk of cardiovascular disease ...

Apple's smartwatch has a heart monitor now

September 13, 2018
There will soon be another way to monitor your heart—from your wrist.

3-D virtual simulation gets to the 'heart' of irregular heartbeats

September 12, 2018
In a proof of concept study, scientists at Johns Hopkins report they have successfully performed 3-D personalized virtual simulations of the heart to accurately identify where cardiac specialists should electrically destroy ...

Dairy consumption linked to lower rates of cardiovascular disease and mortality

September 12, 2018
Dairy consumption of around three servings per day is associated with lower rates of cardiovascular disease and mortality, compared to lower levels of consumption, according to a global observational study of over 130,000 ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.